Davicon, Inc.
United StatesFDA applicant, unverified
- Devices
- 2
What Davicon, Inc. makes
Davicon, Inc. manufactures biofeedback systems and MEDAC systems, which are designed for therapeutic and diagnostic applications in clinical settings. These devices are intended to provide real-time physiological feedback and assist in medical assessments or rehabilitation protocols.
The company’s portfolio is regulated under FDA’s Class II device classification, with products authorised via the 510(k) pathway. These devices are listed in the FDA’s 510(k) database, and the company operates from the United States.
Catalogue
Biofeedback System/3 Ref K914920
Regimes: 510(k) Registry: 510(k)Medac System/3 Ref K914925
Regimes: 510(k) Registry: 510(k)
Frequently asked questions
How many devices does Davicon, Inc. have in the registry?
The registry currently lists 2 devices for Davicon, Inc.. Devices recorded under merged duplicate company entries are counted once.
Which registries list Davicon, Inc.'s devices?
Among its 2 most recently registered devices, Davicon, Inc. has devices listed in FDA 510(k) (2 devices).
What risk classes do Davicon, Inc.'s devices fall under?
Among its 2 most recently registered devices, the classes recorded for Davicon, Inc.'s devices are Class II. Each device page shows its own class and authorisation.
What are the newest devices from Davicon, Inc. in the registry?
The most recently registered devices listed for Davicon, Inc. include BIOFEEDBACK SYSTEM/3 and MEDAC SYSTEM/3.